Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension
Maria G. Frid, B.A. McKeon, Joshua M. Thurman et al. · American Journal of Respiratory and Critical Care Medicine · 2019
Abstract Rationale Pulmonary hypertension (PH) is a life-threatening cardiopulmonary disorder in which inflammation and immunity have emerged as critical early pathogenic elements. Although proinflammatory processes in PH and pulmonary arterial hypertension (PAH) are the focus of extensive investigation, the initiating mechanisms remain elusive. Objectives We tested whether activation of the complement cascade is critical in regulating proinflammatory and pro-proliferative processes in the initiation of experimental hypoxic PH and can serve as a prognostic biomarker of outcome in human PAH. Methods We used immunostaining of lung tissues from experimental PH models and patients with PAH, analyses of genetic murine models lacking specific complement components or circulating immunoglobulins, cultured human pulmonary adventitial fibroblasts, and network medicine analysis of a biomarker risk panel from plasma of patients with PAH. Measurements and Main Results Pulmonary perivascular-specific activation of the complement cascade was identified as a consistent critical determinant of PH and PAH in experimental animal models and humans. In experimental hypoxic PH, proinflammatory and pro-proliferative responses were dependent on complement (alternative pathway and component 5), and immunoglobulins, particularly IgG, were critical for activation of the complement cascade. We identified Csf2/GM-CSF as a primary complement-dependent inflammatory mediator. Furthermore, using network medicine analysis of a biomarker risk panel from plasma of patients with PAH, we demonstrated that complement signaling can serve as a prognostic factor for clinical outcome in PAH. Conclusions This study establishes immunoglobulin-driven dysregulated complement activation as a critical pathobiological mechanism regulating proinflammatory and pro-proliferative processes in the initiation of experimental hypoxic PH and demonstrates complement signaling as a critical determinant of clinical outcome in PAH.
Cited by 118 works. doi:10.1164/rccm.201903-0591oc
Authors
- Maria G. Frid
- B.A. McKeon
- Joshua M. Thurman
- Bradley A. Maron
- Min Li
- Sushil Kumar
- Jennifer Laskowski
- Mehdi A. Fini
- Samantha Hu
- Rubin M. Tuder
- Aneta Gandjeva
- Martin R. Wilkins
- Christopher J. Rhodes
- Pavandeep Ghataorhe
- Jane A. Leopold
- Rui‐Sheng Wang
- Vernon Michael Holers
- Kurt R. Stenmark
References
- A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene
- Sterile inflammation: sensing and reacting to damage
- Arthritis Critically Dependent on Innate Immune System Players
- Generation of C5a in the absence of C3: a new complement activation pathway
- Uncovering disease-disease relationships through the incomplete interactome
- Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
- Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
- Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice
- Hypoxia-Induced Pulmonary Vascular Remodeling Requires Recruitment of Circulating Mesenchymal Precursors of a Monocyte/Macrophage Lineage
- The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity